Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics Total Long Term Liabilities 2010-2025 | NKTR

Nektar Therapeutics total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
  
Nektar Therapeutics Annual Total Long Term Liabilities
(Millions of US $)
2024 $182
2023 $216
2022 $276
2021 $352
2020 $346
2019 $218
2018 $351
2017 $365
2016 $409
2015 $431
2014 $341
2013 $426
2012 $372
2011 $133
2010 $366
2009 $320
Nektar Therapeutics Quarterly Total Long Term Liabilities
(Millions of US $)
2025-03-31 $172
2024-12-31 $182
2024-09-30 $191
2024-06-30 $206
2024-03-31 $217
2023-12-31 $216
2023-09-30 $231
2023-06-30 $247
2023-03-31 $261
2022-12-31 $276
2022-09-30 $285
2022-06-30 $298
2022-03-31 $311
2021-12-31 $352
2021-09-30 $336
2021-06-30 $335
2021-03-31 $338
2020-12-31 $346
2020-09-30 $211
2020-06-30 $215
2020-03-31 $214
2019-12-31 $218
2019-09-30 $474
2019-06-30 $429
2019-03-31 $433
2018-12-31 $351
2018-09-30 $351
2018-06-30 $356
2018-03-31 $358
2017-12-31 $365
2017-09-30 $405
2017-06-30 $400
2017-03-31 $405
2016-12-31 $409
2016-09-30 $417
2016-06-30 $423
2016-03-31 $426
2015-12-31 $431
2015-09-30 $202
2015-06-30 $340
2015-03-31 $346
2014-12-31 $341
2014-09-30 $349
2014-06-30 $429
2014-03-31 $418
2013-12-31 $426
2013-09-30 $352
2013-06-30 $363
2013-03-31 $367
2012-12-31 $372
2012-09-30 $377
2012-06-30 $259
2012-03-31 $262
2011-12-31 $133
2011-09-30 $138
2011-06-30 $358
2011-03-31 $364
2010-12-31 $366
2010-09-30 $311
2010-06-30 $314
2010-03-31 $318
2009-12-31 $320
2009-09-30 $297
2009-06-30 $297
2009-03-31 $300
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.130B $0.098B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.007B 31.89
Zoetis (ZTS) United States $73.637B 27.48
Daiichi Sankyo, - (DSNKY) Japan $51.945B 26.43
Takeda Pharmaceutical (TAK) Japan $46.424B 9.23
Sandoz Group AG (SDZNY) Switzerland $21.498B 0.00
Summit Therapeutics (SMMT) United States $19.339B 0.00
Merck (MKKGY) Germany $16.886B 12.37
United Therapeutics (UTHR) United States $14.237B 12.60
Shionogi (SGIOY) Japan $13.900B 13.93
Neurocrine Biosciences (NBIX) United States $12.176B 41.71
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.318B 25.20
Corcept Therapeutics (CORT) United States $8.234B 66.94
Stevanato Group S.p.A (STVN) Italy $7.023B 42.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.014B 0.00
Grifols, S.A (GRFS) Spain $5.624B 0.00
Ionis Pharmaceuticals (IONS) United States $5.162B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.993B 10.49
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Hypermarcas (HYPMY) Brazil $2.707B 17.81
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.260B 12.22
BioCryst Pharmaceuticals (BCRX) United States $2.210B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.943B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.730B 0.00
Indivior (INDV) United States $1.660B 7.04
ARS Pharmaceuticals (SPRY) United States $1.458B 0.00
Evotec AG (EVO) Germany $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.358B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.257B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.078B 21.57
Harrow (HROW) United States $0.951B 0.00
Ardelyx (ARDX) United States $0.935B 0.00
Collegium Pharmaceutical (COLL) United States $0.929B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.875B 0.00
Enliven Therapeutics (ELVN) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
Akebia Therapeutics (AKBA) United States $0.756B 0.00
Xeris Biopharma Holdings (XERS) United States $0.748B 0.00
AleAnna (ANNA) United States $0.601B 0.00
Elite Pharmaceuticals (ELTP) United States $0.575B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.553B 12.02
Regulus Therapeutics (RGLS) United States $0.549B 0.00
Xencor (XNCR) United States $0.537B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.458B 0.00
Zevra Therapeutics (ZVRA) United States $0.455B 0.00
Altimmune (ALT) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.435B 9.09
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.427B 0.00
CytoDyn (CYDY) United States $0.421B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Verve Therapeutics (VERV) United States $0.378B 0.00
Savara (SVRA) United States $0.369B 0.00
Organogenesis (ORGO) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 9.27
Heron Therapeutics (HRTX) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.88
MediWound (MDWD) Israel $0.228B 0.00
ProKidney (PROK) United States $0.207B 0.00
Nanobiotix S.A (NBTX) France $0.189B 0.00
Journey Medical (DERM) United States $0.183B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Esperion Therapeutics (ESPR) United States $0.165B 0.00
Avita Medical (RCEL) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
4D Molecular Therapeutics (FDMT) United States $0.161B 0.00
OmniAb (OABI) United States $0.158B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.133B 0.00
Larimar Therapeutics (LRMR) United States $0.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Liminatus Pharma (LIMN) $0.119B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.091B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.89
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Inotiv (NOTV) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Surrozen (SRZN) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00